4.7 Article

An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development ofEx VivoGene Therapy: Review of Nonproliferative and Proliferative Changes

Franck J. A. Chanut et al.

Summary: Hematopoietic stem cell gene therapy is a successful therapeutic strategy for some genetic disorders, but pre-clinical toxicity studies are complex and interpretation of results from mouse models challenging. It is important to be aware of the background incidence of lesions induced by different conditioning regimens.

HUMAN GENE THERAPY (2021)

Article Biotechnology & Applied Microbiology

Gene-Based Approaches to Inherited Neurometabolic Diseases

Valentina Poletti et al.

HUMAN GENE THERAPY (2019)

Article Clinical Neurology

Metallothioneins are neuroprotective agents in lysosomal storage disorders

Eleonora Cavalca et al.

ANNALS OF NEUROLOGY (2018)

Article Multidisciplinary Sciences

Synergistic effects of treating the spinal cord and brain in CLN1 disease

Charles Shyng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Hematology

Risk of Seizures in Children Receiving Busulphan-Containing Regimens for Stem Cell Transplantation

Desiree Caselli et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

Review Biochemistry & Molecular Biology

Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)

Jacqueline A. Hawkins-Salsbury et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)

Article Multidisciplinary Sciences

Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

Alessandra Biffi et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation

Alessia Capotondo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Medicine, Research & Experimental

Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits mice

Alessandra Biffi et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Medicine, Research & Experimental

Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells

A Biffi et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Multidisciplinary Sciences

Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice

P Gupta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)